高危皮肤鳞状细胞癌的管理
Management of high-risk cutaneous squamous cell carcinoma.
作者信息
Jennings Lorraine, Schmults Chrysalyne D
机构信息
Mohs Micrographic Surgery Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
出版信息
J Clin Aesthet Dermatol. 2010 Apr;3(4):39-48.
Abstract
Cutaneous squamous cell carcinoma is an increasing public health concern, representing the second most common cancer in the United States. High-risk cutaneous squamous cell carcinoma represents a subgroup of this disease, where patients are at higher risk of metastasis and death. To date, there are no accepted criteria for defining or managing these patients. This review discusses the current state of knowledge of high-risk cutaneous squamous cell carcinoma and outlines reasonable management strategies based on available data.
摘要
皮肤鳞状细胞癌日益引起公众对健康的关注，是美国第二大常见癌症。高危皮肤鳞状细胞癌是该疾病的一个亚组，这类患者发生转移和死亡的风险更高。迄今为止，尚无公认的定义或管理这些患者的标准。本综述讨论了高危皮肤鳞状细胞癌的当前知识状况，并根据现有数据概述了合理的管理策略。
相似文献
1
Management of high-risk cutaneous squamous cell carcinoma.高危皮肤鳞状细胞癌的管理
J Clin Aesthet Dermatol. 2010 Apr;3(4):39-48.
2
Lifestyle factors of smoking, BMI and alcohol on the risk of Non-Melanoma Skin Cancer in adults: a systematic review.吸烟、体重指数和饮酒等生活方式因素对成年人非黑色素瘤皮肤癌风险的影响：一项系统综述。
JBI Libr Syst Rev. 2012;10(6):352-398. doi: 10.11124/01938924-201210060-00001.
3
Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review.高危皮肤鳞状细胞癌的预后变量：综述
J Cutan Pathol. 2016 Nov;43(11):994-1004. doi: 10.1111/cup.12766. Epub 2016 Aug 12.
4
Cutaneous Metastasis From Tonsillar Squamous Cell Carcinoma: Report and Review of the Literature.扁桃体鳞状细胞癌的皮肤转移：病例报告及文献综述
Cureus. 2017 Mar 28;9(3):e1122. doi: 10.7759/cureus.1122.
5
Cutaneous Squamous Cell Carcinoma.皮肤鳞状细胞癌。
Hematol Oncol Clin North Am. 2019 Feb;33(1):1-12. doi: 10.1016/j.hoc.2018.08.001.
6
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.40 基因表达谱检测增强皮肤鳞状细胞癌的转移风险评估。
Future Oncol. 2022 Mar;18(7):833-847. doi: 10.2217/fon-2021-1277. Epub 2021 Nov 25.
7
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.原发性皮肤鳞状细胞癌不良结局的患者风险因素、肿瘤特征和治疗方式的相关性：系统评价和荟萃分析。
JAMA Dermatol. 2023 Feb 1;159(2):160-171. doi: 10.1001/jamadermatol.2022.5508.
8
Aggressive behavior of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者皮肤鳞状细胞癌的侵袭性行为。
Laryngoscope. 2014 Sep;124(9):2043-8. doi: 10.1002/lary.24586. Epub 2014 Feb 10.
9
Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data.头颈部皮肤鳞状细胞癌腮腺转移与颈部转移的预后比较：基于新出现数据的一份新报告
Braz J Otorhinolaryngol. 2021 Jul-Aug;87(4):389-395. doi: 10.1016/j.bjorl.2019.10.007. Epub 2019 Nov 15.
10
Risk Factors and Mortality in Cutaneous Squamous Cell Carcinoma of the Head and Neck.头颈部皮肤鳞状细胞癌的危险因素与死亡率
Actas Dermosifiliogr (Engl Ed). 2020 May;111(4):325-328. doi: 10.1016/j.ad.2018.09.025. Epub 2020 Apr 25.
引用本文的文献
1
Squamous Cell Carcinoma: A Clinical and Histopathological Review of a South African Tertiary Dermatology Unit.鳞状细胞癌：南非一家三级皮肤科单位的临床与组织病理学综述
J Skin Cancer. 2025 Jun 20;2025:8884436. doi: 10.1155/jskc/8884436. eCollection 2025.
2
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.自我监督的人工智能在诊断时可预测原发性皮肤鳞状细胞癌的不良预后。
NPJ Digit Med. 2025 Feb 15;8(1):105. doi: 10.1038/s41746-025-01496-3.
3
Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.头颈部皮肤鳞状细胞癌中的神经周围浸润
Cancers (Basel). 2024 Nov 1;16(21):3695. doi: 10.3390/cancers16213695.
4
Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic Targets.颠覆皮肤癌治疗格局：PD-1/PDL-1 和 CTLA-4 作为关键治疗靶点的崛起。
Curr Drug Targets. 2024;25(15):1012-1026. doi: 10.2174/0113894501320281240822052657.
5
The Immune Response of Cutaneous Basosquamous- and Squamous-Cell Carcinoma Associated with Sun Exposure.与阳光暴露相关的皮肤基底细胞鳞状细胞癌的免疫反应。
Curr Oncol. 2024 Apr 28;31(5):2481-2487. doi: 10.3390/curroncol31050185.
6
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.皮肤鳞状细胞癌的分子靶向治疗：最新进展与临床意义
EXCLI J. 2024 Feb 27;23:300-334. doi: 10.17179/excli2023-6489. eCollection 2024.
7
Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosis.自监督人工智能可在诊断时预测原发性皮肤鳞状细胞癌的复发、转移和疾病特异性死亡。
Res Sq. 2023 Dec 13:rs.3.rs-3607399. doi: 10.21203/rs.3.rs-3607399/v1.
8
Large Cutaneous Squamous Cell Carcinoma: A Consequence of Elective Surgery Deferment During the COVID-19 Pandemic.大型皮肤鳞状细胞癌：COVID-19大流行期间择期手术延期的后果。
Cureus. 2023 Nov 3;15(11):e48195. doi: 10.7759/cureus.48195. eCollection 2023 Nov.
9
Increased Risk of Local Recurrence in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed Skin: A Retrospective Cohort Study.日光暴露皮肤发生的皮肤鳞状细胞癌局部复发风险增加：一项回顾性队列研究。
Cancers (Basel). 2023 Oct 18;15(20):5037. doi: 10.3390/cancers15205037.
10
The clinicopathological and microrna expression signature associated with lymphovascular invasion in squamous cell carcinoma: A basic descriptive study.与鳞状细胞癌中淋巴管侵犯相关的临床病理及微小RNA表达特征：一项基础描述性研究。
Health Sci Rep. 2022 Nov 25;5(6):e958. doi: 10.1002/hsr2.958. eCollection 2022 Nov.
本文引用的文献
1
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.莫氏外科医生对高危皮肤鳞状细胞癌围手术期管理的不确定性。
Arch Dermatol. 2010 Nov;146(11):1225-31. doi: 10.1001/archdermatol.2010.323.
2
Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.环式光动力疗法治疗实体器官移植受者可降低鳞状细胞癌发病率。
Dermatol Surg. 2010 May;36(5):652-8. doi: 10.1111/j.1524-4725.2009.01384.x. Epub 2009 Nov 4.
3
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study.受累神经的直径可预测伴有神经周围侵犯的皮肤鳞状细胞癌的结局：一项研究者设盲的回顾性队列研究。
Dermatol Surg. 2009 Dec;35(12):1859-66. doi: 10.1111/j.1524-4725.2009.01354.x.
4
Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness.莫氏手术与传统手术切除治疗面部和耳部非黑色素瘤皮肤癌的成本效益分析
Dermatol Surg. 2009 Nov;35(11):1776-87. doi: 10.1111/j.1524-4725.2009.01291.x. Epub 2009 Sep 8.
5
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.非黑色素瘤皮肤癌治疗方式基于相对价值单位的成本比较：莫氏多次手术减免优惠取消的影响
J Am Acad Dermatol. 2009 Jul;61(1):96-103. doi: 10.1016/j.jaad.2008.07.047.
6
7
Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.在莫氏显微外科手术中对非黑色素瘤皮肤癌进行创新的19分钟快速细胞角蛋白免疫染色。
Dermatol Surg. 2009 Jul;35(7):1050-6. doi: 10.1111/j.1524-4725.2009.01182.x. Epub 2009 May 15.
8
Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.西妥昔单抗治疗一名患有严重隐性营养不良性大疱性表皮松解症患者的转移性皮肤鳞状细胞癌。
Dermatology. 2009;219(1):80-3. doi: 10.1159/000218714. Epub 2009 May 13.
9
Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes.高危皮肤鳞状细胞癌的手术单药治疗与手术联合辅助放疗：结局的系统评价
Dermatol Surg. 2009 Apr;35(4):574-85. doi: 10.1111/j.1524-4725.2009.01095.x.
10
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].吉非替尼与静脉注射甲氨蝶呤治疗复发性头颈部鳞状细胞癌的III期研究[校正后]
J Clin Oncol. 2009 Apr 10;27(11):1864-71. doi: 10.1200/JCO.2008.17.0530. Epub 2009 Mar 16.
Zotero 插件